98 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
5 Mar 24
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:31am
harbor provisions of the Private Securities Litigation Reform Act of 1995.
GOSSAMER BIO, INC.
CONDENSED CONSOLIDATED FINANCIAL STATEMENT DATA
8-K
EX-10.1
GOSS
Gossamer Bio Inc
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
satisfaction/growth; customer service; employee satisfaction; recruitment and maintenance of personnel; human resources management; supervision of litigation
8-K
EX-99.1
GOSS
Gossamer Bio Inc
9 Nov 23
Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
7:31am
in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Gossamer
424B3
owdy6qqohkuhnn 9ow8l
28 Aug 23
Prospectus supplement
4:29pm
S-3
xm2nic5058h6 qw
18 Aug 23
Shelf registration
8:41am
S-3ASR
stw2oty18dvpn7b2
17 Aug 23
Automatic shelf registration
4:01pm
8-K
EX-99.1
gqbfs75kv lkwix035c2
8 Aug 23
Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update
4:01pm
8-K
EX-99.1
7o8mspkls0rkke td2z
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
89sghhv
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
EX-10.1
onpq 5993k4jhw14
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
EX-99.1
d9wy7xnu
20 Jul 23
Interim TORREY OLE Update and PROSERA Phase 3 Design July 2023
7:50am
8-K
EX-99.1
qutzrm wlf
9 May 23
Gossamer Bio Announces First Quarter 2023 Financial Results and Provides Business Update
4:03pm
PRE 14A
q1019oa 6mw
17 Apr 23
Preliminary proxy
4:01pm
8-K
romk666wltsqzra
6 Dec 22
Other Events
7:36am
8-K
EX-99.1
y73l8uqj
6 Dec 22
Other Events
7:36am